Myriad Genetics | MYGN - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Myriad Genetics

Myriad Genetics reported $800K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.


Ordinary Share Capital Change
Accelerate Diagnostics AXDX:US USD 100K 3K
Agilent A:US USD 3M 0
Becton, Dickinson and Co. BDX:US USD 365M 0
Danaher DHR:US USD 9M 0
Exact Sciences EXAS:US USD 1.8M 19K
Hologic HOLX:US USD 3M 0
J&J JNJ:US USD 3.12B 0
Myriad Genetics MYGN:US USD 800K 0
NanoString Technologies NSTG:US USD 5K 0
OraSure Technologies OSUR:US USD 0 0
Quest Diagnostics DGX:US USD 2M 0
Repligen RGEN:US USD 556K 0
Veracyte VCYT:US USD 72K 0
Waters WAT:US USD 1.63M 2K